Macroaxis: Personalized Investing
Simple Personalized Investing

FNMFO FNMFO 096770 KDDIF Junk Bonds Insurance Macroaxis 20 Diversified Assets 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for ^GSPC and AMDCX ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 S&P 500  vs   AMIDEX35 Israel C
Check Correlation Matrix  
Daily Returns (%)
GSPC   AMDCX   
 
Assuming 30 trading days horizon, S&P 500 is expected to generate 0.87 times more return on investment than AMIDEX35. However, S&P 500 is 1.16 times less risky than AMIDEX35. It trades about 0.34 of its potential returns per unit of risk. AMIDEX35 Israel C is currently generating about -0.01 per unit of risk. If you would invest  159,361  in S&P 500 on April 26, 2013 and sell it today you would earn a total of  5,599  from holding S&P 500 or generate 3.51% return on investment over 30 days.

Diversification

Very weak diversification
Overlapping area represents amount of risk that can be diversified away by holding S&P 500 and AMIDEX35 Israel C in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.42
Parameters
Time Period1 Month [change]
DirectionPositive AMDCX Moved Up vs ^GSPC
StrengthWeak
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between GSPC and AMDCX with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between GSPC and AMDCX to your reader
 
Share Correlation between GSPC and AMDCX 
Find Opportunities
 
Predicted Return Density
 
Returns   
GSPC   AMDCX   

S&P 500

 
    
SP 500
Performance
18
Out Of
100
Over 30
Days
    

Match-ups for SP 500

Glu Mobile Inc vs. S&P 500
Ricks Cabaret International Inc vs. S&P 500
Ameriana Bancorp vs. S&P 500
AT T Inc vs. S&P 500
iShares High Dividend Equity vs. S&P 500
iShares S P US Preferred Stock Index vs. S&P 500
Apple Inc vs. S&P 500
StemCells Inc vs. S&P 500
SoundBite Communications Inc vs. S&P 500
US Concrete Inc vs. S&P 500
Southcoast Financial Corp vs. S&P 500
Pitney Bowes Inc vs. S&P 500
  

AMIDEX35 Israel C

 
    
AMIDEX35
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days AMIDEX35 Israel C has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match-ups for AMIDEX35

DFA International Small Company I vs. AMIDEX35 Israel C
IVA International A vs. AMIDEX35 Israel C
IVA International I vs. AMIDEX35 Israel C
IVA International C vs. AMIDEX35 Israel C
Vanguard International Explorer Inv vs. AMIDEX35 Israel C
Oakmark International Small Cap I vs. AMIDEX35 Israel C
Oakmark International Small Cap II vs. AMIDEX35 Israel C
Vanguard FTSE AllWld exUS SmCp Idx I vs. AMIDEX35 Israel C
Vanguard FTSE AllWld exUS SmCp Idx Inv vs. AMIDEX35 Israel C
Franklin Intl Small Cap Growth Adv vs. AMIDEX35 Israel C


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium